Related Topics News -

     
 Title only   |   Print    Next page > 
     
《業績》翰思艾泰中期虧損擴大至3,688.3萬元

2026-08-17T  
翰思艾泰四項核心臨床前研究成果於AACR年會亮相

2026-04-24T  
翰思艾泰四項創新藥將於AACR年會發表壁報研究成果

2026-04-12T  
《業績》翰思艾泰全年虧損擴大至1.31億人幣 不派息

2026-03-27T  
翰思艾泰首席財務官變動

2026-02-05T  
翰思艾泰候選藥物HX111完成首例病人用藥

2026-02-04T  
翰思艾泰穩定價格期結束 超額配股權失效

2026-01-25T  
翰思艾泰(03378.HK)創新藥HX111獲准開展臨床試驗

2025-12-23T  
《新股》翰思艾泰(03378.HK)公開發售超購3,073倍 一手中籤率1%

2025-12-22T  
《新股》翰思艾泰招股入場費3,232.27元 引7名基石投資者

2025-12-15T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.